Related Experiment Videos
Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing
J K Larsen1, A Gjerris, P Holm
1Department of Psychiatry, Frederiksberg Hospital, Denmark.
Acta Psychiatrica Scandinavica
|December 1, 1991
Abstract:
Moclobemide was compared with isocarboxazide and clomipramine in patients with depression. A total of 167 outpatients were allocated to daily treatment with 300 mg moclobemide, 30 mg isocarboxazide or 150 mg clomipramine for 6 weeks. Moclobemide was slightly inferior to clomipramine, whereas isocarboxazide had an intermediate position. There was no interaction between treatment and atypical or nonatypical depression. Anticholinergic symptoms and orthostatic hypotension were most pronounced in the clomipramine group.